Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.

In light of Pope Francis’ pneumonia diagnosis, Dr. Leana Wen explains why older adults are especially at risk for serious ...

but poses a threat to all age groups and may lead to more serious respiratory illnesses, such as pneumonia, in the elderly and those who are immunocompromised. "We found that on average ...

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

Breakthrough infections in immunocompromised individuals are a significant concern due to persistent viral shedding and the potential emergence of new SARS-CoV-2 variants. Given that neutralising ...

approximately 40% of immunocompromised participants did not seroconvert or achieve a conservative neutralization threshold postvaccination," according to the group's research letter, published in ...

For the immunocompromised ... insight into the impact that COVID-19 continues to have on those patient groups across different geographies. As our data shows, vaccination alone is often not ...

Noroviruses are increasingly recognized as an important cause of chronic gastroenteritis in immunocompromised patients, as reflected by the growing number of clinical case reports. This review ...

Live-attenuated viral vaccines (LAV) have been used safely for several decades in healthy individuals to protect against diseases with great success. In immunocompromised hosts their use is ...

Researchers found that people aged 60 and older who are immunocompromised exhibited weaker immune responses to RSV vaccines compared to healthy individuals in the same age group. Both vaccines are ...